Meetings and Workshops
Upcoming Meetings and Workshops
No events found. Please change event type and try again.
Previous Meetings and Workshops
Extension of comment period on the notice of intent to ist benzophenone, coconut oil diethanolamine condensate (cocamide diethanolamine), diethanolamine and 2-methylimidazole as known to the state to cause cancer.
to
Comment period on the notice of intent to list: Benzophenone, coconut oil diethanolamine condensate (cocamide diethanolamine), diethanolamine and 2-methylimidazole as known to the state to cause cancer.
to
Comment Period - Notice of Modification of Proposed Regulation Title 27, California Code of Regulations, Amendment to Section 25705 - Specific Regulatory Levels Posing No Significant Risk: Chlorothalonil
to
On September 23, 2011, OEHHA published a notice in the California Regulatory Notice Register (Register 2011, No. 38-Z) proposing to establish a specific regulatory level posing no significant risk for Imazalil by amending Title 27, California Code of Regulations, section 25705.
to
Extension of public comment period regarding the removal of the reference to hexavalent chromium in Section 25707(b)(4) as posing no significant risk when ingested.
to
Extension of comment period regarding the establishment of a specific regulatory level posing no significant risk for Imazalil.
Extension of public comment period on the changed notice of proposed rulemaking establishing a No Significant Risk Level: 4-Methylimidazole (4-MEI).
to
Announcement of the October 12th and 13th2011 CIC meeting and hazard ID materials for fluoride and its salts, and tris(1,3-Dichloro-2-Propyl) phosphate. Both will be considered for listing at the October 2011 meeting.
to
Comment period for the Changed Notice of Proposed Rulemaking Specific Regulatory Levels Posing No Significant Risk: 4-Methylimidazole (4-MEI).
to
Notice to propose establishment of a specific regulatory level posing no significant risk for imazalil and amend Title 27, California Code of Regulations, section 25705.
to